Just ask Rebecca Cherubini. She has been struggling with multiple sclerosis for 15 years.

"I surrendered it to God," she said, "I'm like, 'If this is your will, I would love for You to change it. But if not, ok, then You need to give me the grace to deal.'"

Like most people with MS, Cherubini's came out of the blue when she was young.

"Blurred vision to the point where I started to become nervous about my driving," she recalled. "And then one day I was actually going to work and I pulled off."

In addition to vision problems, other symptoms include fatigue, trouble walking and difficulty thinking.

MS is an autoimmune disease. That's when the body's immune system mistakenly attacks healthy tissue. In the case of MS, the immune system attacks the outer portion of nerves in the brain and the spinal cord. It gets worse over time, and there is no cure.

"I want to be able to drive my kids to soccer," Cherubini said. "I don't want to be debilitated. I don't want to be in a wheelchair."

Now, Cherubini may get her wish. She's one of dozens of MS patients at the Ohio State Medical Center to test a new drug called Ocrelizumab.

The medicine works to stop the cells in the immune system from attacking the central nervous system. It's clearly effective. It's been shown to stop the disease in its tracks—not just the more common "relapsing" form of MS, but also the most aggressive type, called "primary progressive."

"Ocrelizumab was the first medication for primary progressive MS that actually worked," said Dr. Michael Racke, a neurologist at the Ohio State Wexner Medical Center who has been treating MS patients for 30 years.

He says patients call it a game-changer.

"They say, 'You know, I really haven't had any kinds of effects from my MS,' and that's really obviously quite satisfying as an MS physician who can remember the days when we really didn't have anything to treat patients," he said.

Cherubini told Dr. Racke she's delighted the drug has stopped the progression of her disease. (Screengrab: Ocrelizumab/via CBN News)

"I feel normal again. I was telling him, I just feel normal," she said.

Ocrelizumab is not like other MS drugs, such as the pills that have to be taken daily or the shots that come three times a week. It only involves an infusion, which typically lasts four hours, every six months.

"This medicine, I don't have to worry about it," Cherubini said. "I don't have to take it every day. I don't have to worry about ordering it. I don't have to worry about any reactions to it."

Ocrelizumab costs $65,000 a year, which believe it or not, is less than many of the leading MS drugs.

And while this breakthrough can stop the progression of MS, doctors still don't know what causes the disease, so prevention remains a mystery.

"If you look at identical twins, when one twin gets MS, 70 percent of the time the other identical twin, who clearly has the same genetics as their brother or sister, doesn't get MS," explained Dr. Racke.

Since MS is an inflammatory disease, things that cause inflammation, such as obesity, stress and smoking, could factor-in. Early studies show vitamin D might help prevent it.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Will Graham: Satisfy Your Longing Soul in 2026

Top New Year's Resolutions: Americans Want More Family Time and Prayer in 2026

'Hero' Mom Jumps into Water to Save 4-year-old Daughter Who Fell Between Cruise Ship and Dock

ICYMI: President Trump Delivered a Huge Christmas Gift to US With Newest Pharma Deal

Facts Flip Voters' View of Trump Economy, Thwarting Media Misinformation

Over Christmas, the US Struck the Islamic State in Nigeria

People of Iran Keep Rising Up against Tyranny...

WA Somali-Run Daycare Took $210,000 In Taxpayer Funds in 2025 But No Childcare Business Appears to Exist: Report

In Light of Fraud Allegations, Trump's HHS Pauses Funding for Minnesota Child Care Centers, Implements Verification

'Children Do Not Belong to the Government': Federal Judge Smacks Down CA Gender Secrecy Policies

Fed Judge Rules Trump Admin CAN Share Immigrants' Medicaid Data With ICE

[Watch] Shocking Unearthed Footage Shows Parents Pretending to Drop Kids Off at a Minnesota Day Care Center

Minnesota Fraud Scandal Exposes the Real Crisis Facing the West

Buried for 2,000 Years: Ancient Mikveh Discovered Beneath Western Wall Plaza

A Christian Response to the Terror Threats that Loom over New Year's Celebrations

'Landmark Achievement': New Puerto Rico Law Recognizes Unborn Children as People from Conception

Tariffs to Transgender Athletes: SCOTUS Cases to Watch in 2026

Homeland Security's Staggering Accomplishments in One Year, Including Finding Nearly 130,000 Missing Children

Ex-Atheist Filmmaker Explores Scientific Evidence for God in New Movie

Women’s Group Files to Get ‘Transgender’ Men Out of Female Prisons in Canada